确定安全网医院中乳腺癌高危患者的服务需求:缩小差距的方法。
Defining the Need for Services for Patients at High Risk of Breast Cancer at a Safety-Net Hospital: An Approach to Narrowing the Disparities Gap.
发表日期:2024 Aug 13
作者:
Olivia Cheng, Caroline Fiser, Jamie Paysour, Ruchi Aluwalia, Aysia Hilliard, Cletus Arciero, Clara R Farley, Jade Jones, Jesse Conyers, Lauren M Postlewait
来源:
ANNALS OF SURGICAL ONCOLOGY
摘要:
国家乳腺癌认证计划 (NAPBC) 标准最近进行了修订,以促进乳腺癌 (BC) 风险评估和随后的高风险服务转诊。该项目旨在估计作者安全网医院系统中 BC 高风险患者的比例,衡量患者对高风险服务的兴趣,并确定项目开发资源。 2023 年 2 周内接受乳腺成像的女性被调查。排除了 35 名有 BC 病史或诊断的患者。 Tyrer-Cuzick (TC) 模型版本 8 用于计算 BC 风险。高/中风险定义为 10 年风险为 5% 或以上,终生风险为 15% 或以上,或两者兼而有之。遗传咨询和检测转诊标准基于国家综合癌症网络指南。共有 257 名患者进行了 TC 风险评估,显示 14.8%(n = 38)的 10 年 BC 风险为 5% 或更高(考虑到内分泌治疗),6.2% (n = 16) 的终生 BC 风险为 20% 或更高(有资格进行年度筛查 MRI),10.5% (n = 27) 的终生 BC 风险为 15% 或更高(考虑到高风险筛查)。 257 名患者中有 61 名 (23.7%) 符合遗传咨询/检测标准。总体而言,31.5%(n = 81)有资格进行高/中风险筛查、风险降低和/或遗传评估/测试,其中 92.8% 对转诊以获得更多信息和护理感兴趣。在作者社区中,几乎三分之一接受乳腺成像的患者有资格获得 BC 高风险评估和服务。大多数患者表示有兴趣寻求此类服务。这些数据将用于财务规划和资源分配,以便根据 NAPBC 指南在作者的机构制定高风险计划。他们希望这些努力能够改善社区 BC 的肿瘤结果和生存率。© 2024。外科肿瘤学会。
The National Accreditation Program for Breast Cancer (NAPBC) standards were recently revised to promote breast cancer (BC) risk assessment and subsequent referral for high-risk services. This project sought to estimate the proportion of patients at high risk for BC in the authors' safety-net hospital system, gauge patient interest in high-risk services, and define resources for program development.Women presenting for breast imaging during 2 weeks in 2023 were surveyed. Thirty-five patients with a history or diagnosis of BC were excluded. The Tyrer-Cuzick (TC) model version 8 was used to calculate BC risk. High/intermediate risk was defined as a 10-year risk of 5% or more, a lifetime risk of 15% or more, or both. The criteria for genetic counseling and testing referral were based on National Comprehensive Cancer Network guidelines.A total of 257 patients had a TC risk assessment showing 14.8% (n = 38) with a 10-year BC risk of 5% or more (consideration of endocrine therapy), 6.2% (n = 16) with a lifetime BC risk of 20% or more (qualifying for annual screening MRI), and 10.5% (n = 27) with a lifetime BC risk of 15% or more (consideration of high-risk screening). The criteria for genetic counseling/testing were met by 61 (23.7%) of the 257 patients. Overall, 31.5% (n = 81) qualified for high/intermediate-risk screening, risk reduction, and/or genetic assessment/testing, 92.8% of whom were interested in referrals for additional information and care.In the authors' community, almost one third of patients undergoing breast imaging qualify for BC high-risk assessment and services. The majority of the patients expressed interest in pursuing such services. These data will be used in financial planning and resource allocation to develop a high-risk program at the authors' institution in line with NAPBC guidelines. They are hopeful that these efforts will improve oncologic outcomes and survival from BC in their community.© 2024. Society of Surgical Oncology.